News & AnalysisFineHeart inks Series BFineHeart S.A, a preclinical medical device company, has secured 15 million euros in Series B funding.ByIris Dorbian1 June 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs